Oval Medical announces the availability of functional prototypes

30th May 2013 – Oval Medical Technologies Ltd (‘Oval’), today have announced that functional prototypes of their autoinjector technology are now available. Oval’s specification for a standard 1ml device was clearly met by delivering 1ml of drug subcutaneously, through a 27G needle in less than 7 seconds. The fully functional injection-moulded prototypes demonstrate the simplicity […]

Continue Reading

Revolutionary autoinjector pushes the limits of high viscosity drug delivery

17th April 2013 – Oval Medical Technologies Ltd (‘Oval’), today have announced that a variety of 1100 cPs solutions (the thickness of motor oil) have been successfully delivered through a 25G thin wall needle, in less than 7 seconds, using their revolutionary autoinjector. Oval is a cutting-edge autoinjector company based in Cambridge UK. Their autoinjector […]

Continue Reading

Oval Medical receives ISO 13485:2012 certification for medical device development

21st February 2013 – Oval Medical Technologies Ltd (‘Oval’), the privately held autoinjector development company, today announced that is has been awarded BS EN ISO 13485:2012 certification. ISO 13485 is a quality standard certifying that the company has a comprehensive management system in place for the design, development and manufacture of drug delivery devices. This […]

Continue Reading

Oval Medical Technologies signs key agreement with leading global pharmaceutical company

May 14th, 2012 – Oval Medical Technologies Ltd. (“Oval”), the company developing the next generation of autoinjectors, today announced that they have entered into an agreement with a top ten global pharmaceutical company to evaluate one of their leading prescription drugs in Oval’s novel autoinjector technology. Under the terms of Agreement, the pharmaceutical company has […]

Continue Reading

Oval Medical collaborates with the Cambridge University MBA Venture Project

6th February 2012 – Cambridge-based Oval Medical Technologies Limited (“Oval Medical”) has recently collaborated on the Cambridge Venture Project (CVP), part of the MBA programme at the Judge Business School, University of Cambridge. Oval Medical has developed a unique autoinjector and syringe technology that will allow patients of different ages and from various therapeutic areas […]

Continue Reading

Oval Medical expands with two new hires

Monday, 18 July 2011 -The autoinjector development company Oval Medical Technologies ltd, has today announced further expansion with two new appointments of a Programme Manager and a Design Engineer. Alison Kwok joins the company in the capacity of Programme Manager from Owen Mumford where she held the post of Technical Project Manager for the past […]

Continue Reading

Oval signs two feasibility deals with pharmaceutical companies

11th April 2011 – Oval Medical Technologies Ltd., the company developing the next generation of autoinjector technology, announced today that they have entered into two deals with pharmaceutical companies who are putting Oval’s primary drug containment technology through feasibility trials. Oval’s CEO Matthew Young has said, ‘These two deals have been signed at a key […]

Continue Reading

Next generation autoinjector shows clear superiority

10th January 2011 – Oval Medical Technologies Ltd., the Cambridge based autoinjector company today announced results from two user studies in which Oval’s novel, proprietary autoinjector clearly demonstrated superiority compared with two well-known autoinjector devices currently on the market. The Oval next generation autoinjector is designed to be smaller, easier and safer to use than […]

Continue Reading

Oval Medical featured in ONdrugDELIVERY

Oval Medical Technologies Limited is based in Cambridge and has broad expertise in design and development of drug delivery devices focusing on vials, prefilled syringes and autoinjectors. The company was born out of what it saw as a need for radical innovation in the design of autoinjectors.

Continue Reading